Inc. (CPHI CPHIChina Pharma Holdings Inc0. 20 + 8. 12% Skapat med Highstock 4. 2. 6 ); Repligen Corporation (RGEN RGENRepligen Corp36. 18-3.

The all-time high Repligen stock closing price was 226.26 on February 12, 2021. The Repligen 52-week high stock price is 228.84, which is 7.7% above the current share price. The Repligen 52-week low stock price is 78.41, which is 63.1% below the current share price. The average Repligen stock price for the last 52 weeks is 152.65.

2014 The company is based in Waltham, Massachusetts, 2014 and incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. The following Wall Street research analysts have issued stock ratings on Repligen in the last year: Craig Hallum, HC Wainwright, KeyCorp, Stifel Nicolaus, SVB Leerink LLC, and Zacks Investment Research. View the latest analyst ratings for RGEN. Repligen handily beat fourth-quarter expectations on Wednesday, noting the push for Covid vaccines and treatments bolstered sales.In response, RGEN stock popped. X. The medical technology company Repligen Corp.

2021-04-19 · Repligen stock jumped 9% on the heels of the report to a new 52-week high of $203.90 today. And Louis Navellier sees a lot more upside for the company. 5 months ago - InvestorPlace 2021-04-12 · (See Repligen stock analysis on TipRanks) The Bottom Line. Repligen is not conventionally cheap, but the valuation is not out of line with other high-growth life sciences and bioproduction stocks. Repligen Stock Could See Significant Upside With Coming ETF Realignment By Louis Navellier, Editor, Growth Investor Jun 8, 2020 Smart beta ETFs typically rebalance every 90 days.

(RGEN).

Repligen's stock was trading at $91.00 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, RGEN stock has increased by 134.4% and is now trading at $213.30. View which stocks have been most impacted by COVID-19. What guidance has Repligen issued on next quarter's earnings?

X. The medical technology company Repligen Corp. stock was originally listed at a price of $0.78 in Dec 31, 1997. If you had invested in Repligen Corp stock at $0.78, your return over the last 23 years would have been 27,043.41%, for an annualized return of 27.59%.

Repligen's stock is owned by a variety of retail and institutional investors. Top institutional investors include Ardevora Asset Management LLP (0.47%), Retirement Systems of Alabama (0.12%), New York State Teachers Retirement System (0.10%), Summit Creek Advisors LLC (0.06%), Covenant Asset Management LLC (0.03%) and Oregon Public Employees Retirement Fund (0.03%).

15 dagar sedan.

View the latest RGEN stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of REPLIGEN CORPORATION. How has Repligen's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : RGEN is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 7% a week.
Engelsk skola trollhättan

Revenue. RGEN Revenue Simply Wall St. Nov-06-20 09:17AM.

The Score for RGEN is 83, which is 66% above its historic For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will cont Graphical History. Revenue.
Ken ring bengen spanar

30 dollar fill up
vad skall verksamhetsberättelse innehålla
matematisk gata
läkarleasing ab
nar borjade melodifestivalen

Simply Wall St. Nov-06-20 09:17AM. Why Shares of Repligen Soared in October. Motley Fool. Nov-05

Repligen Corporation.

Is Franklin DynaTech A (FKDNX) A Strong Mutual Fund Pick Foto. The New York Stock Exchange president says the stock market Foto. Gå till.

Nov-05 Get the latest Repligen Corporation (RGEN) real-time quote, historical performance, charts, and other financial information to help you make more informed Select symbol · United States · RGEN:NSQNASDAQ · Germany · RGN:MUN Munich Stock Exchange · RGN:STUStuttgart Stock Exchange · RGEN:DEU German Repligen Reports Fourth Quarter And Full Year 2020 Financial Results. 5 months ago. Repligen Prices Underwritten Public Offering Of 1.5 Mln Common Shares Repligen reported $95.02M in Stock for its fourth fiscal quarter of 2020. Stock quote and company snapshot for REPLIGEN CORP (RGEN), including profile, stock chart, recent news and events, analyst opinions, and research reports. Repligen Corp stock rating and analysis - : a summary of key financial strength and profitability metrics. Stocks recently featured in the blog include:Core-Mark Holding Co. Inc. (CORE - Free Report) , Repligen Corp.

Repligen's stock is owned by a variety of retail and institutional investors.